Central nervous system and peripheral effects of ACTH, MSH, and related neuropeptides.
Adrenocorticotropic Hormone (ACTH), Melanocyte-Stimulating Hormone (MSH), and related peptides have been shown to have several neurogenic effects: alteration of cerebral protein synthesis, RNA synthesis, protein phosphorylation, and neurotransmitter turnover. Furthermore, there appears to be an ACTH containing circuit in the CNS which originates in the arcuate nucleus. Changes in concentration of the peptides in this family have been shown to alter electrophysiology, neuromuscular function, and behavior (e.g., grooming, learning) in infrahuman subjects. These findings suggest that the neuropeptides MSH and ACTH influence the capacity of an organism to efficiently evaluate information and influence the affective functioning of humans.
D000324:Adrenocorticotropic Hormone / Q000494:pharmacology*; D000339:Affect / Q000187:drug effects; D000818:Animals; D001288:Attention / Q000187:drug effects; D001519:Behavior / Q000187:drug effects*; D001921:Brain / Q000187:drug effects* / Q000502:physiology; D005071:Evoked Potentials / Q000187:drug effects; D006120:Grooming / Q000187:drug effects; D006801:Humans; D009074:Melanocyte-Stimulating Hormones / Q000494:pharmacology*; D009469:Neuromuscular Junction / Q000187:drug effects*; D051381:Rats
D000324:Adrenocorticotropic Hormone; D009074:Melanocyte-Stimulating Hormones